<?xml version="1.0" encoding="UTF-8"?>
<p id="Par26">The PACER trial is a multicentre study performed in six academic and five teaching hospitals in the Netherlands. We plan to include 392 patients in 36 months, with a potential limit of 462 patients to accommodate loss to follow-up and possible dropout.</p>
